|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls008413854 |
| 003 |
SK-MaSNL |
| 005 |
20260303070230.0 |
| 008 |
040806c2005 xo 0 slo |
| 015 |
|
|
|a SNBCL2005/5
|
| 035 |
|
|
|a SLK034922
|
| 040 |
|
|
|a SLKCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
1 |
|
|a slo
|b eng
|b slo
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.69-008.1-085
|2 1981
|
| 100 |
1 |
|
|a Vrabec, Ján,
|d 1950-2006
|4 aut
|9 13377
|
| 245 |
1 |
0 |
|a Zásady testosterónovej substitúcie a podávania Tadalafilu pri erektílnej dysfunkcii v dôsledku andropauzy
|c Ján Vrabec
|
| 246 |
1 |
0 |
|a Principles of testosteron substitution and feeding Tadalafil near erectile dysfunction in consequence of andropause
|
| 246 |
1 |
1 |
|a Principles of testosteron substitution and feeding Tadalafil near erectile dysfunction in consequence of andropause
|
| 504 |
|
|
|a Res. ang., slov.
|
| 504 |
|
|
|a Bibliogr. odkazy
|
| 650 |
0 |
7 |
|a erekcia penisu
|x účinky liekov
|2 MESH
|9 1067374
|
| 650 |
0 |
7 |
|a testosterón
|x analógy a deriváty
|2 MESH
|9 1067375
|
| 650 |
0 |
7 |
|a andropauza
|2 MESH
|9 845596
|
| 650 |
0 |
7 |
|a faktory rizikové
|2 MESH
|9 838956
|
| 650 |
0 |
7 |
|a nádory
|x komplikácie
|2 MESH
|9 866497
|
| 650 |
0 |
7 |
|a dysfunkcie psychosexuálne
|x diagnostika
|2 MESH
|9 1067376
|
| 650 |
0 |
7 |
|a kvalita života
|2 MESH
|9 1705
|
| 773 |
0 |
|
|w SERIAL_GENERAL*000250*2005*005*002
|x 1335-3071
|t Urológia
|g Roč. 11, č. 2 (2005), s. 37-39
|
| 850 |
|
|
|a Slovenská lekárska knižnica v Bratislave
|a BA006
|
| 852 |
|
|
|a BA006
|b KIS3GCP
|b 000500000
|
| 999 |
|
|
|c 1754494
|d 1756424
|
